Actividad fungicida/fungistática in vitro del fosfito de manganeso contra hongos patógenos habitantes del suelo con soja

Las pudriciones de raíz y tallo (PRYT) en el cultivo de soja causadas por patógenos habitantes del suelo son enfermedades comúnmente encontradas en campos de soja y son una de las causas más importantes de pérdidas económicas. La sensibilidad micelial de Fusarium virguliforme, Fusarium tucumaniae, Sclerotinia sclerotiorum y Macrophomina phaseolina fue evaluada en medio de cultivo agar papa glucosa (25 mL) suplementado con diferentes concentraciones (µg mL-1) de fosfito de manganeso (PhiMn) diluido en agua (0; 25; 37.5; 50; 100; 200; 300; 400; 500; 800 y 1000). La sensibilidad del crecimiento micelial fue analizada usando análisis de regresión lineal logarítmico. La concentración de PhiMn necesaria para inhibir el 50% del crecimiento micelial (CI50) fue calculada. Los valores de CI50 fueron desde 105 µg mL-1 (Fusarium spp.) hasta 409 µg mL-1 (M. phaseolina). La formación de esclerocios fue completamente inhibida a 500 µg mL-1. Los resultados del presente estudio representan el primer reporte de la acción fungicida/fungistática in vitro del Phi contra los hongos agentes causales de PRYT en el cultivo de soja.Soybean root and stem rots caused by soil-borne pathogens are diseases commonly found in soybean fields, and one of the most important causes of crop losses. In the present study, the mycelial sensitivity of Fusarium virguliforme, F. tucumaniae, Sclerotinia sclerotiorum and Macrophomina phaseolina was evaluated on potato dextrose agar media (25 mL) supplemented with different concentrations of manganese phosphite (MnPhi) diluted in water (0, 25, 37.5, 50, 100, 200, 300, 400, 500, 800 and 1000 µg/mL). Mycelial growth sensitivity was analyzed using logarithmic linear regression analysis. The MnPhi concentration needed to inhibit 50% of the mycelial growth (IC50) ranged from 105 µg/mL (Fusarium spp.) to 409 µg/mL (M. phaseolina). Sclerotia were completely inhibited at 500 µg/mL. The results of our study represent the first report on the direct in vitro fungicidal/fungistatic action of MnPhi against fungi that are causal agents of soil-borne diseases.Fil: Carmona, Marcelo Anibal. Universidad de Buenos Aires. Facultad de Agronomía. Departamento de Producción Vegetal. Cátedra de Fitopatología; ArgentinaFil: Simonetti, Ester. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones en Biociencias Agrícolas y Ambientales. Universidad de Buenos Aires. Facultad de Agronomía. Instituto de Investigaciones en Biociencias Agrícolas y Ambientales; Argentina. Universidad de Buenos Aires. Facultad de Agronomía. Departamento de Biología Aplicada y Alimentos. Cátedra de Microbiología Agrícola; ArgentinaFil: Ravotti, M. E.. Universidad de Buenos Aires. Facultad de Agronomía. Departamento de Producción Vegetal. Cátedra de Fitopatología; ArgentinaFil: Scandiani, María Mercedes. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; ArgentinaFil: Luque, A. G.. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; ArgentinaFil: Formento, N. A.. Instituto Nacional de Tecnología Agropecuaria. Centro Regional Entre Ríos. Estación Experimental Agropecuaria Paraná; ArgentinaFil: Sautua, Francisco. Universidad de Buenos Aires. Facultad de Agronomía. Departamento de Producción Vegetal. Cátedra de Fitopatología; Argentin

Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance

Vascular endothelial growth factor-A (VEGF-A) has been demonstrated to play an important role in tumour angiogenesis and to influence prognosis in many cancers. However its prognostic value in head and neck squamous cell carcinomas (HNSCCs) remains controversial. Therefore, we investigated the clinical relevance of VEGF-A expression in HNSCCs and analysed whether its expression was associated with PAIP2 protein levels, a VEGF-A mRNA-binding partner that strongly regulates VEGF-A expression in tissue culture. We determined the correlation of VEGF-A and PAIP2 protein levels, quantitatively evaluated in tumour tissue homogenates from 54 patients with HNSCC, to clinicopathological parameters. We showed that VEGF-A expression in HNSCC is correlated to the stage of tumour differentiation (P=0.050) and is an independent prognostic factor for progression-free survival (P=0.001) and overall survival (P=0.0004). In a pharynx carcinoma cell line, we demonstrated by RNA interference that VEGF-A expression is closely controlled by PAIP2. Moreover, in human HNSCCs, VEGF-A expression is significantly correlated to PAIP2 protein levels (P=0.0018). Nevertheless, PAIP2 expression is associated with neither clinicopathological factors nor patient's survival. Our data suggest that, in contrast to PAIP2 protein levels, which are unrelated to tumour prognosis, VEGF-A expression could serve as a prognostic marker in head and neck cancer and may be helpful for targeted therapies

Gait Analysis through a visual method to calculate temporal parameters: comparison of performance between the gait laboratory and the clinical setting

Analysis of human movement providessystematic and quantitative information of movement. The detection of eventsthat occur during walking allows for the calculation of spatiotemporalparameters, commonly used for the characterization of gait. A method for visualdetection of gait events was previously evaluated, showing promising results.The method should now be used in the clinical setting for estimation of gaitparameters and symmetry. The aims of this study were then to compare theperformance of the visual method in a clinical setting against its performancein a gait laboratory and to evaluate its behavior for calculation of gaitsymmetry in eight healthy subjects. Two gait events were detected and sixtemporal parameters (TP) were calculated. Also, a symmetry index (SI) wascalculated for three TP. Results for the calculation of TP in the clinicalsetting were comparable to those obtained in the gait laboratory. Also, thevalues of TP and symmetry were within the range of those reported by otherauthors. These results suggest that the visual events detection method can beconsidered as an option for basic Analysis of Human Movement in the clinicalenvironment.Fil: de Grucci, Carla. Universidad Nacional de Entre Ríos. Facultad de Ingeniería; ArgentinaFil: Bonell, C. E.. Universidad Nacional de Entre Ríos; ArgentinaFil: Dutto, César Ignacio. Hospital Integral del Discapacitado Dr. Vera Candioti; ArgentinaFil: Barrera, Verónica. Hospital Integral del Discapacitado Dr. Vera Candioti; ArgentinaFil: Bernal, Cecilia. Hospital Integral del Discapacitado Dr. Vera Candioti; ArgentinaFil: Catalfamo Formento, Paola Andrea Lucia. Universidad Nacional de Entre Ríos. Instituto de Investigación y Desarrollo en Bioingeniería y Bioinformática - Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Investigación y Desarrollo en Bioingeniería y Bioinformática; Argentin

Spatio temporal parameters and symmetry in subjects ascending and descending a ramp, using three different prosthetic feet

This is a post-peer-review, pre-copyedit version of an article published in Journal of Mechanical Science and Technology. The final authenticated version is available online at: https://doi.org/10.1007/s12206-020-0145-

Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients

The long-term prognostic value of tumoural MDR1 and MRP, along with p53 and other classical parameters, was analysed on 85 node-positive breast cancer patients receiving anthracycline-based adjuvant therapy. All patients underwent tumour resection plus irradiation and adjuvant chemotherapy (the majority receiving fluorouracil–epirubicin–cyclophosphamide). Median follow-up for the 54 alive patients was 7.8 years. Mean age was 53.7 years (range 28–79) and 54 patients were post-menopausal. MDR1 and MRP expression were quantified according to an original reverse transcription polymerase chain reaction multiplex assay with colourimetric enzyme-linked immunosorbent assay detection(β2-microglobulin as control). P53 protein was analysed using an immunoluminometric assay (Sangtec). MDR1 expression varied within an 11-fold range (mean 94, median 83), MRP within a 45-fold range (mean 315, median 242) and p53 protein from the limit of detection (0.002 ng mg−1) up to 35.71 ng mg−1(mean 1.18, median 0.13 ng mg−1). P53 protein was significantly higher in oestrogen receptor (ER)-negative than in ER-positive tumours (P = 0.039). The higher the p53, the lower the MDR1 expression (P = 0.015, r = –0.27). P53 was not linked to progesterone receptor (PR) status, S phase fraction, or MRP. Significantly greater MDR1 expression was observed in grade I tumours (P = 0.029). No relationship was observed between MDR1 and MRP. Neither MDR1 nor MRP was linked to ER or PR status. Unlike MDR1, MRP was correlated with the S phase: the greater the MRP, the lower the S phase (P = 0.006, r = –0.42). Univariate Cox analyses revealed that MDR1, MRP, p53 and S phase had no significant influence on progression-free or specific survival. A tendency suggested that the greater the p53, the shorter the progression-free survival (P = 0.076 as continuous and 0.069 as dichotomous). © 2000 Cancer Research Campaig

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

The prognostic value of tumoural epidermal growth factor receptor (EGFR), p53, thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) was analysed on 82 advanced head and neck cancer patients (71 men, 11 women; mean age 59). Induction treatment was cisplatin–5-FU ± folinic acid (61 patients, Chem group) or concomitant cisplatin–5-FU–radiotherapy (21 patients, RChem group). EGFR (binding assay), p53 protein (Sangtec immunoluminometric assay), TS and DPD activities (radioenzymatic assays) were measured on biopsies obtained at time of diagnosis. Significant positive correlation was demonstrated between p53 and EGFR. In the RChem group, p53 was higher in non-complete responders (median 1.03 ng mg−1) than in complete responders (median 0.08 ng mg−1) (P = 0.057). Univariate Cox analyses stratified on treatment group showed that specific survival (33 events) was significantly related to T staging, p53 taken as continuous or categorial (below vs over 0.80 ng mg−1) variable, and EGFR (below vs over 220 fmol mg−1); survival increased when EGFR and p53 were below thresholds. Multivariate stepwise analysis including T staging, EGFR and p53 revealed that T staging and EGFR were independent predictors of survival; relative risks were 3.68 for T staging and 2.65 for EGFR. Overall, EGFR remained an independent prognostic factor when response to treatment and T staging were considered in the multivariate analysis. © 1999 Cancer Research Campaig

MELISSA: Laser ion source setup at CERN-MEDICIS facility. Blueprint

The Resonance Ionization Laser Ion Source (RILIS) has become an essential feature of many radioactive ion beam facilities worldwide since it offers an unmatched combination of efficiency and selectivity in the production of ion beams of many different chemical elements. In 2019, the laser ion source setup MELISSA is going to be established at the CERN-MEDICIS facility, based on the experience of the workgroup LARISSA of the University Mainz and CERN ISOLDE RILIS team. The purpose is to enhance the capability of the radioactive ion beam supply for end users by optimizing the yield and the purity of the final product. In this article, the blueprint of the laser ion source, as well as the key aspects of its development and operation are presented. © 2019 Elsevier B.V.This research project has been supported by a Marie Skłodowska-Curie Innovative Training Network Fellowship of the European Commission's Horizon 2020 Programme under contract number 642889 MEDICIS-PROMED; by a Research and Innovation Programme of the European Commission's Horizon 2020 under contract number 654002 (ENSAR2-RESIST); by a grant from the French National Agency for Research called “Investissements d'Avenir”, Equipex Arronax-Plus no. ANR-11-EQPX-0004 and Labex IRON no. ANR-11-LABX-18-01; by FWO-Vlaanderen (Belgium), and by a KU Leuven START Grant; by the German Federal Ministry of Education and Research under the consecutive projects 05P12UMCIA and 05P15UMCIA

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy

<p>Abstract</p> <p>Background</p> <p>Vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis involving in carcinogenesis, including lung cancer. We hypothesized that <it>VEGF </it>polymorphisms may affect survival outcomes among locally advanced non-small cell lung cancer (LA-NSCLC) patients.</p> <p>Methods</p> <p>We genotyped three potentially functional <it>VEGF </it>variants [-460 T > C (rs833061), -634 G > C (rs2010963), and +936 C > T (rs3025039)] and estimated haplotypes in 124 Caucasian patients with LA-NSCLC treated with definitive radiotherapy. We used Kaplan-Meier log-rank tests, and Cox proportional hazard models to evaluate the association between <it>VEGF </it>variants and overall survival (OS).</p> <p>Results</p> <p>Gender, Karnofsky's performance scores (KPS) and clinical stage seemed to influence the OS. The variant C genotypes were independently associated with significantly improved OS (CT+CC vs. TT: adjusted hazard ratio [HR] = 0.58; 95% confidence interval [CI] = 0.37-0.92, <it>P </it>= 0.022), compared with the <it>VEGF </it>-460 TT genotype.</p> <p>Conclusions</p> <p>Our study suggests that <it>VEGF </it>-460 C genotypes may be associated with a better survival of LA-NSCLC patients after chemoradiotherapy. Large studies are needed to confirm our findings.</p